|
ATRX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.09490000399504E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.14160003461939E-09 |
| Normal-vs-Stage2 |
8.838600E-03 |
| Normal-vs-Stage3 |
6.618700E-04 |
| Normal-vs-Stage4 |
9.56099999949167E-07 |
| Stage1-vs-Stage2 |
5.968600E-01 |
| Stage1-vs-Stage3 |
6.279000E-01 |
| Stage1-vs-Stage4 |
2.377800E-01 |
| Stage2-vs-Stage3 |
9.349400E-01 |
| Stage2-vs-Stage4 |
2.392800E-01 |
| Stage3-vs-Stage4 |
2.039600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.65849997361079E-09 |
| Normal-vs-AfricanAmerican |
2.87850000002532E-06 |
| Normal-vs-Asian |
3.587600E-04 |
| Caucasian-vs-AfricanAmerican |
7.114600E-01 |
| Caucasian-vs-Asian |
6.032200E-01 |
| AfricanAmerican-vs-Asian |
5.333600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54680046549061E-10 |
| Normal-vs-Female |
2.585600E-02 |
| Male-vs-Female |
7.74410000000669E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.63389999996433E-06 |
| Normal-vs-Extreme_Weight |
9.0407015207461E-11 |
| Normal-vs-Obese |
1.370760E-04 |
| Normal-vs-Extreme_Obese |
2.05289999999358E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.820600E-01 |
| Normal_Weight-vs-Obese |
2.453400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.372800E-01 |
| Extreme_Weight-vs-Obese |
1.041770E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.984400E-01 |
| Obese-vs-Extreme_Obese |
2.553400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.371800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.54555999999362E-05 |
| Normal-vs-Age(61-80Yrs) |
1.19879994819883E-09 |
| Normal-vs-Age(81-100Yrs) |
8.33530000021732E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.903400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.537900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.496300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.279800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.092390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.228600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.11600004185186E-09 |
| Normal-VS-Type2 PRCC |
1.80639999625143E-08 |
| Normal-VS-KIRP CIMP |
1.717970E-01 |
| Normal-VS-Unclassified PRCC |
2.665800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.398200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.959800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.143770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.177800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.107830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.783400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61119995123471E-09 |
| Normal-vs-N1 |
1.010380E-02 |
| Normal-vs-N2 |
1.329610E-02 |
| N0-vs-N1 |
1.107380E-01 |
| N0-vs-N2 |
5.593200E-01 |
| N1-vs-N2 |
7.559400E-01 |
|
|
